Gradual dose escalation of GLP-1 medications, following FDA-approved titration schedules, helps minimize gastrointestinal side effects that may indirectly contribute to muscle symptoms through reduced intake and activity
In a TODAY segment that aired on Nov
We investigated pre-July 2017 FAERS data, predating the approval of GLP-1RA for pediatric use, and identified 80 cases of AEs in children related to GLP-1RA, suggesting the existence of off-label use
Regular doses also contribute to significant metabolic improvements
Heres a practical breakdown of every path available and how to determine which one makes the most sense for you
Staying hydrated, maintaining fiber intake, and following our nutrition guidance keeps this manageable for most patients